AOAksel Ozdemır

Aksel Ozdemır

*This is an algorithmically generated author record based on publicly available information.

Aksel Ozdemır has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence of COVID-19 in patients with parkinson’s disease and the impact of parkinson’s disease on COVID-19 prognosis

    by Demet Yildiz, Nilüfer Büyükkoyuncu Pekel, Melih Yüksel, Aksel Özdemir, Ebru Çetin Kenan, Muhammed Furkan Öztürkci

    Objective This study aimed to retrospectively evaluate the prevalence of COVID-19 infection among patients with Parkinson’s disease (PD), along with the clinical course and factors associated with mortality. Methods A total of 1,786 patients diagnosed with Parkinson’s disease and registered at our hospital were screened. Among these, 222 had undergone PCR testing for COVID-19, of whom 76 tested negative and 152 tested positive, indicating a COVID-19 prevalence of 8.51% in the PD population. Due to insufficient data, 63 of the COVID-19 positive patients were excluded. The final study cohort included 177 patients: 89 patients with PD (50.3%) and 88 age- and sex-matched controls (49.7%). Clinical, laboratory, and prognostic parameters were compared between groups. Results The prevalence of dementia was significantly higher in the PD group. Mortality at both 28 and 90 days was also significantly increased among patients with PD. Notably, those receiving combined therapy with dopamine agonists and levodopa had lower mortality rates at both time points. In patients who died within 28 or 90 days, levels of age, neutrophil count, lymphocyte count, D-dimer, ferritin, C-reactive protein (CRP), and troponin differed significantly compared to survivors. Conclusion Patients with Parkinson’s disease represent a vulnerable population at increased risk for adverse outcomes from COVID-19. Close clinical monitoring, continuous dopaminergic treatment, and a personalized approach are essential for optimizing management during COVID-19 infection.

  • Open Access

    The effect of the shock index and scoring systems for predicting mortality among geriatric patients with upper gastrointestinal bleeding: a prospective cohort study

    by Umran Dogru, Melih Yuksel, Mehmet Oguzhan Ay, Halil Kaya, Aksel Ozdemır, Yesim Isler, Mehtap Bulut

    Gastrointestinal (GI) bleeding is an important cause of mortality and morbidity among geriatric patients. To investigate whether the shock index and other scoring systems are effective predictors of mortality and prognosis among geriatric patients presenting to the emergency department with complaints of upper GI bleeding. Prospective cohort study in an emergency department in Bursa, Turkey. Patients over 65 years admitted to a single-center, tertiary emergency service between May 8, 2019, and April 30, 2020, and diagnosed with upper GI bleeding were analyzed. 30, 180 and 360-day mortality prediction performances of the shock index and the Rockall, Glasgow-Blatchford and AIMS-65 scores were evaluated. A total of 111 patients who met the criteria were included in the study. The shock index (P < 0.001) and AIMS-65 score (P < 0.05) of the patients who died within the 30-day period were found to be significantly different, while the shock index (P < 0.001), Rockall score (P < 0.001) and AIMS-65 score (P < 0.05) of patients who died within the 180-day and 360-day periods were statistically different. In the receiver operating characteristic (ROC) analysis for predicting 360-day mortality, the area under the curve (AUC) value was found to be 0.988 (95% confidence interval, CI, 0.971-1.000; P < 0.001). The shock index measured among geriatric patients with upper GI bleeding at admission seems to be a more effective predictor of prognosis than other scoring systems.